Tempus AI (NASDAQ: TEM) has taken Wall Street by storm, ranking among the best-performing equities of 2025. Notably, the ...

A new COVID variant, NB.1.8.1, was detected in Washington. These are the symptoms to watch for and recommended vaccinations.

A new COVID variant, NB 1.8.1, is being detected across California; here are the symptoms to watch for, and vaccinations you'll need to take.

The PD-(L)1xVEGF field had a roller coaster week marked by an imperfect readout and a potentially $11 billion deal. | The PD- ...

Bristol-Myers Squibb and BioNTech announced a major deal worth up to $11 billion in early June. Click here to find out why I ...

Bristol Myers and BioNTech are teaming up to develop and commercialize BNT327, a cancer therapy with blockbuster ambition.

BioNTech SE's $11.1B oncology move signals potential, but clinical hurdles remain. Click for my look at the BNTX deal with ...

BMS will co-develop and co-commercialize BioNTech’s bispecific antibody BNT327 for solid tumors in a deal worth up to $11.1B ...

German-based BioNTech (BNTX), best known for its collaboration with Pfizer (PFE) during the COVID-19 pandemic for developing ...

Truist Securities analysts raised the price target on BioNTech SE (NASDAQ:BNTX) from $151 to $155 and kept a “Buy” rating.